Leverage our leading directory and marketing expertise to showcase your cancer models to a large pool of preclinical biopharma researchers.
Extend your market reach
85% of pharma and biopharma customers work for small and medium companies. We will showcase your models and services to a global network ranging from small biotech companies to top 20 biopharmas.
Generate highly qualified leads
We work closely with researchers to identify their needs and find the right model for them. Our Cancer Model Scout service will only connect them with your organisation if they are highly qualified to work with you.
Our team matches biopharmas with your models based on specific requirements and scientific merit
Researchers can filter models by primary site, model type, gene mutation, treatment response, and more
Scientists have the final say - we only connect biopharmas with your CRO if your model is the best fit
Spark drug research innovation
Our mission is to accelerate the complex cancer drug discovery process. We offer bespoke matching service for biopharmas to help everyone reduce the cost and risks, enabling faster treatment of life threatening diseases.
- Our recommendations are based on scientific merit - CROs big and small are on a level playing field
- We organise and standardise your data, allowing scientists to easily find your models
- Researchers have direct online access to over 8,000 models from verified CROs
Benefits of our collaboration
Visibility through Cancer Models Platform
Get more requests from biopharma reserchears by showcasing your data on our platform. Our standarised and curated catalogue makes your models easy to find, speeding up the drug discovery process and reducing the failure rate.
Bespoke marketing packages for CROs
Our experts will create a marketing package tailored for your organisation, regardless of the size. The options include targeted emails, webinar, events, collaboration on white papers, and more.
Latest industry trends and insight
We keep you updated on the emerging technologies within the preclinical oncology market. Our consultants supply you with applicable reports and advice on generating preclinical cancer study leads.
Case 1: Expand the indications for an already approved drug
A top20 biopharma researcher made a request to search for lung PDX models with an exon-specific mutation in a tyrosine kinase receptor. Our report included 43 new, matching models - more than they’ve gathered over the course of three years.
Case 2: Find the right model faster – speed up translational results
A top20 biopharma researcher was looking for a PDX model from NSCLC tissue with a specific genomic rearrangement in a specific exon of a gene of interest. The researcher and their team had been searching for a PDX model to match these criteria for 2 years with no success.
Case 3: Save time assessing molecular data – for all vendors
A top20 biopharma researcher was seeking to run a mouse clinical trial for PDX models matching specific molecular characteristics based on a gene panel of 15 genes. With the Repositive platform solution all available raw molecular data has been collected, curated, processed and analysed, with confidence in the standardised data analysis.